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A key factor in the effectiveness of the seasonal influenza vaccine is its immunological
compatibility with the circulating viruses during the season. Here we propose a new
bioinformatics approach for analysis of influenza viruses which could be used as an
efficient tool for selection of vaccine viruses, assessment of the effectiveness of seasonal
influenza vaccines, and prediction of the epidemic/pandemic potential of novel influenza
viruses.
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INTRODUCTION
Vaccination is the most effective way to prevent infection with seasonal influenza viruses. As
a consequence of the high evolutionary rate and antigenic drift of influenza viruses, vaccines
are produced annually in preparation of the upcoming season. Generally, the World Health
Organization (WHO) recommends the vaccine for the Northern Hemisphere in February and
production begins once the FDA approves it (Food and Drug Administration, 2014). Evolution
of influenza viruses between the time of vaccine selection and the beginning of the flu season (week
40 for the Northern Hemisphere) can seriously hamper vaccine efficacy. For this reason, in most
years, the flu vaccine is 50 to 70% effective (Center for Disease Control and Prevention, 2014a). This
is especially a concern for influenza A viruses which evolve more rapidly than influenza B viruses
(Nobusawa and Sato, 2006).
For the 2014/15 influenza season, the trivalent United States-licensed influenza vaccine
contains the same virus strains as the 2013/14 version: an A/California/7/2009 (H1N1)-like
virus, an A/Texas/50/2012 (H3N2)-like virus, and a B/Massachusetts/2/2012-like (Yamagata
lineage) virus (Food and Drug Administration, 2014). In contrast to circulating H1N1 and
B viruses, which are genetically similar to their vaccine viruses, 52% of H3N2 viruses
that circulated during this flu season were antigenically different from the H3N2 vaccine
strain (Center for Disease Control and Prevention, 2014b). As a consequence of this
mismatch, the efficacy of the vaccine during the 2014/15 flu season was less than 20%
(Center for Disease Control and Prevention, 2015a). The situation in Europe was even
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worse. The efficacy of the influenza vaccine in the United
Kingdom (UK; period 1 October 2014 to 16 January 2015) was
only 3.4% effective overall and 2.3% specifically against A(H3N2;
Pebody et al., 2015). Phylogenetic analysis has shown that the
2014–2015 influenza viruses in the UK belong in the same genetic
clade (3C) as vaccine strain A/Texas/50/2012, but to different
subgroups (Pebody et al., 2015). However, it is unlikely that this
difference alone explains the very low efficacy of the current
vaccine since its homology score is> 98% (Pebody et al., 2015).
In general, the main weakness of phylogenetic analyses
based on multiple sequence alignment (MSA), is that sequence
similarity does not necessarily imply similarity in biological
properties. For example, two protein sequences that differ by a
single mutation that is lethal for biological function will likely
group together in a phylogeny, whereas two proteins that differ
in several mutations that do not affect biological functions will
be separated. In order to overcome this obstacle and to improve
functional sequence analysis, we recently propose a new distance
measure based on the informational spectrum method (ISM),
representing the virtual spectroscopy method for analysis of
protein-protein interactions (Perovic, 2013; Perovic et al., 2013).
The ISM analysis of hemagglutinin from influenza A viruses
showed that this viral protein encodes a highly conserved region
which is specific for each viral subtype (Veljkovic et al., 2009a,b).
This region, which is represented by a characteristic frequency
in the informational spectrum (IS) of hemagglutinin, determines
the virus/receptor interaction (Veljkovic et al., 2009a,b; Schmier
et al., 2015) and the immunological cross-reactivity between
different viral subtypes (Vergara-Alert et al., 2012).
In this paper, we develop and compare phylogenies based on
MSA versus our IS approach for 2014/15 influenza viruses and
vaccine strains. Our results identify a potential reason for the very
low effectiveness during the 2014/2015 flu season and could also
be used to assess vaccine effectiveness for 2015/2016. In addition,
the IS analysis of human and animal H3N2 viruses circulating
in 2015 in the US revealed a novel swine virus with increased
pandemic potential.
MATERIALS AND METHODS
Viruses
We analyzed the hemagglutinin HA1 region from (i) 2,379 H3N2
viruses collected in Europe and North America from January
2014 to February 2015, (ii) 804 human and animal H3N2 viruses
collected in the US from January to August 2015 (non-redundant
sequences are given inData Sheet 1) that were stored in GISAID
(GISAID database1 and (iii) vaccine viruses A/Texas/50/2012 and
A/Switzerland/9715293/2013 for 2014/2015 and 2015/2016 flu
season, respectively.
Informational Spectrum Method
The ISM is the virtual spectroscopy method for calculation
of the long-range properties of biological macromolecules
(Veljkovic et al., 1983). The ISM is based on the electron-ion
interaction potential (EIIP) representing molecular descriptor
1http://platform.gisaid.org.
which determines long-range interactions (interactions on
distances >5Å) between biological molecules. This parameter is
defined by the following equation:
EIIP = 0.25
Z∗ sin(1.04pi Z∗)
2pi
(1)
where Z∗ is the average quasivalence number (AQVN)
determined by
Z∗ =
1
N
m∑
i= 1
niZi (2)
where Zi is the valence number of the i-th atomic component, ni
is the number of atoms of the i-th component, m is the number
of atomic components in the molecule, andN is the total number
of atoms. The EIIP values calculated according to equations (1)
and (2) are expressed in Rydberg (Ry) units.
The ISM consists of three basic steps:
1. Transformation of alphabetic code of primary protein
structure into a sequence of numbers representing EIIP of
each component.
2. Conversion of numerical sequence by fast Fourier
Transformation into information spectrum, which reveals
dominant frequency peaks representing information encoded
in the primary structure of protein.
3. Extraction of common information which is encoded in
primary structure of proteins by calculation of the Consensus
Information Spectrum (CIS).
The Phylogenetic Analysis
We used the ISM-based phylogenetic algorithm (ISTREE;
Perovic, 2013; Perovic et al., 2013) to generate the phylogenetic
tree of the HA1 influenza segment. We previously describe our
ISTREE algorithm (Perovic, 2013; Perovic et al., 2013) and in
Figure 1, we provide a schematic (For access to ISTREE, we
refer the reader to http://istree.bioprotection.org). Here, we used
an ISM distance measure d defined on the specific frequency
F = 0.2988. This frequency was extracted by CIS as the common
frequency component for novel H3N2 HA1.
For development of the conventional phylogenetic tree based
on MSA-based, we used the MEGA5 (Tamura et al., 2011)
software package. For the MSA calculation of sequences the
MUSCLE algorithm of MEGA5 software was applied.
RESULTS
Our calculation of the CIS for H3N2 HA1 showed that these
proteins are characterized with the common biological property
represented with the IS frequency F(0.299). In Figure 2A and
Supplementary Image 2, we present the ISM-based phylogenetic
tree for HA1 from H3N2 viruses collected in United States
(US) from January 2014 to February 2015 (Data Sheet 2). We
constructed this tree using the amplitude on the frequency
F(0.299) as a distance matrix of the HA1 sequences. As can
be seen (Figure 2A and Supplementary Image 2), the viruses
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FIGURE 1 | The schematic presentation of the ISTREE algorithm.
formed two separated clusters A and B. This difference is not
visible in the MSA-based phylogenetic tree (Figure 2B and
Supplementary Image 3).
In Figure 3, we show the ISM-based and MSA-based
phylogenetic tree for HA1 from viruses collected in UK from
January 2014 to February 2015. These viruses also are grouped
in two separate clusters A and B. Of note is that that number
of viruses in group B is significantly higher than in the group A
suggesting that these viruses dominate in the 2014/15 flu season
in the US and the UK. According to the IS concept, viruses from
group A and B have different interacting and immunological
profiles (Vergara-Alert et al., 2012; Perovic, 2013; Perovic et al.,
2013). As can be seen in Figures 2A, 3A, H3N2 vaccine strain
A/Texas/50/2012 belongs to the smaller group A, and does not
match viruses from the dominant group B. It is possible cause for
the low vaccine efficacy in this season.
In Figure 4 and Supplementary Image 1, we show the ISM-
based phylogenetic analysis of H3N2 viruses of animal and
human origin isolated in US from January to August 2015. The
tree reveals a cluster (group C) of variant human-like swine
H3N2 viruses (H3N2v), which are distinct from groups A and
B. This result indicates that the current 2015/16 seasonal vaccine
will not provide adequate protection against H3N2v in the event
of an epidemic.
To assess protective capacity of current and previous seasonal
vaccines against novel H3N2v virus, we compared informational
spectrum of HA from human H3N2v (A/Minnesota/38/2015)
and vaccine H3N2 viruses used from 1995 to 2015. The results
(Figure 5) suggest that not one of the current and previous
H3N2 vaccines could give effective protection against H3N2v
viruses.
Until August 2015 H3N2v viruses are circulating only in the
US Middle-East of US and are not present in other parts of the
country (Figure 6). Close monitoring of the dynamics of the
further spread of H3N2v in US and neighboring countries will
be important for assessment of the pandemic potential of this
virus.
DISCUSSION
The MSA-based phylogenetic algorithms are commonly used for
analysis of the evolution of viruses. These approaches, although
give some useful information about the evolution of influenza
viruses, also have some serious drawbacks. The main weaknesses
of the MSA-based phylogenetic algorithms for analysis of protein
sequences are (i) insensitivity to position of the mutations,
(ii) failure to consider deletion within sequence, and (iii) lack
of the information about biological effect of mutations (e.g.,
two protein sequences that differ by a single mutation that is
lethal for biological function will likely group together in a
phylogeny, whereas two proteins that differ in several mutations
that do not affect biological functions will be separated). In order
to overcome these drawbacks of the MSA-based phylogenetic
analysis of influenza viruses, a novel IS-based algorithm was
proposed (Perovic, 2013; Perovic et al., 2013). This phylogenetic
algorithm allows (i) assessment of biological effect of each
particular mutation and (ii) analysis of the functional evolution
of proteins (Perovic, 2013; Perovic et al., 2013; Schmier et al.,
2015). Here we develop and compare phylogenesis based on
MSA versus ISM for 2014/15 influenza viruses and vaccine
strains.
In February 2015, the World Health Organization. (2015)
recommended an A/Switzerland/9715293/2013 (H3N2)-like
virus as a vaccine strain for the 2015/16 season (16). Our analysis
of the HA gene segment from this virus suggests that it belongs
to group B of circulating H3N2 viruses (Figures 2, 3) and thus is
an appropriate choice for the vaccine.
Since 2011, clinicians and public health professionals
discovered H3N2v viruses in the US that had HA segments
similar to seasonal H3 strains and a matrix (M) gene similar to
2009 H1N1 pandemic viruses (Nelson et al., 2012; Rajão et al.,
2015; Center for Disease Control and Prevention, 2015b). The
NA gene of these viruses is of the contemporary human N2
lineage (Rajão et al., 2015). Moreover, the naturally occurring
mutations in the H3N2v HA are associated with antigenic
divergence from human and swine H3 viruses that circulate in
US and from current swine and human vaccine strains (Rajão
et al., 2015). These results together with our here presented
results for viruses isolated during 2015 in US suggest the
fast evolution of novel H3N2v toward viruses with increased
pandemic potential.
CONCLUSION
Using an ISM-based phylogenetic analysis, we identified two
distinct clades for 2014/15H3N2 seasonal influenza in theUS and
the UK. We found that the majority of circulating viruses for this
season belonged to a clade that is genetically different from the
vaccine strain. This result was not observed using conventional
phylogenetic approaches thus highlighting the potential for ISM
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FIGURE 2 | Phylogenetic analysis of H3N2 viruses collected in North America from January 2014 to February 2015. (A) The ISM-based phylogenetic tree;
(B) The MSA-based phylogenetic tree.
FIGURE 3 | Phylogenetic analysis of H3N2 viruses collected in England from January 2014 to February 2015. (A) The ISM-based phylogenetic tree; (B) The
MSA-based phylogenetic tree.
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FIGURE 4 | The ISM-based phylogenetic tree of H3N2 viruses collected in US from January to August 2015.
FIGURE 5 | The Phylogenetic analysis of H3N2 vaccine viruses and human H3N2v A/Minnesota/38/2015.
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FIGURE 6 | Distribution of novel H3N2v circulating in 2015 in US.
as a mechanism to support vaccination design. Our results
also suggest that the influenza vaccine recommended by WHO
for season 2015/16 will be effective against circulating H3N2
viruses. Because of fast evolution of influenza viruses it not
possible to exclude the possibility that new escape mutants
will appear during the 2015/16 season. For this reason, further
ISM-based phylogenetic monitoring of influenza viruses will be
useful.
Our analysis of variant human-like swine H3N2v
viruses which spreads in 2015 across the Middle-East
of US indicates pandemic potential of this virus. This
analysis also suggests that the seasonal influenza vaccine is
not efficient against H3N2v. Further close monitoring of
evolution and spread of H3N2v is critical for prevention
of a possible pandemic which could be caused by this
virus.
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